These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 24964660

  • 1. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S, Oncul O, Aktas Z, Acar A, Ozyurt M, Turhan V, Erdem H, Gorenek L.
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [Abstract] [Full Text] [Related]

  • 2. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 3. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M, Dandache I, Araj GF, Wakim R, Kanj S, Kanafani Z, Khairallah M, Sabra A, Shehab M, Dbaibo G, Matar GM.
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [Abstract] [Full Text] [Related]

  • 4. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S, Mallick SK, Bose S.
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [Abstract] [Full Text] [Related]

  • 5. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, Tsioka A, Roilides E, Sofianou D, Gritsi-Gerogianni N.
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [Abstract] [Full Text] [Related]

  • 6. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S, Chandran SP, Shamanna P, Macaden R.
    Indian J Med Microbiol; 2012 Dec; 30(1):93-5. PubMed ID: 22361769
    [Abstract] [Full Text] [Related]

  • 7. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY, Chuang YC, Siu LK, Wu TL, Lin JC, Lu PL, Wang JT, Wang LS, Lin YT, Huang LJ, Fung CP.
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [Abstract] [Full Text] [Related]

  • 8. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ, Lagacé-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance.
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [Abstract] [Full Text] [Related]

  • 9. Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.
    Akpaka PE, Legall B, Padman J.
    West Indian Med J; 2010 Dec; 59(6):591-6. PubMed ID: 21702229
    [Abstract] [Full Text] [Related]

  • 10. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
    Baykal A, Cöplü N, Simşek H, Esen B, Gür D.
    Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
    [Abstract] [Full Text] [Related]

  • 11. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 12. Investigation of carbapenem resistance and the first identification of Klebsiella pneumoniae carbapenemase (KPC) enzyme among Escherichia coli isolates in Turkey: A prospective study.
    Kuskucu MA, Karakullukcu A, Ailiken M, Otlu B, Mete B, Aygun G.
    Travel Med Infect Dis; 2016 Jun; 14(6):572-576. PubMed ID: 27890667
    [Abstract] [Full Text] [Related]

  • 13. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M, Sekar U.
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [Abstract] [Full Text] [Related]

  • 14. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z, Zhu D, Zhang Y, Wang F.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1476-9. PubMed ID: 12509910
    [Abstract] [Full Text] [Related]

  • 15. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
    Hernández JR, Pascual A, Cantón R, Martínez-Martínez L, Grupo de Estudio de Infección Hospitalaria. GEIH.
    Enferm Infecc Microbiol Clin; 2003 Feb 10; 21(2):77-82. PubMed ID: 12586030
    [Abstract] [Full Text] [Related]

  • 16. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep 10; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

  • 17. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
    Roy S, Datta S, Viswanathan R, Singh AK, Basu S.
    J Antimicrob Chemother; 2013 May 10; 68(5):1036-42. PubMed ID: 23335112
    [Abstract] [Full Text] [Related]

  • 18. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M, Tassios PT, Avlamis A, Stefanou I, Kosmidis C, Platsouka E, Paniara O, Xanthaki A, Toutouza M, Daikos GL, Tzouvelekis LS.
    J Antimicrob Chemother; 2008 Jan 10; 61(1):59-63. PubMed ID: 17999975
    [Abstract] [Full Text] [Related]

  • 19. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
    Nazik H, Ongen B, Ilktac M, Aydin S, Kuvat N, Sahin A, Yemisen M, Mete B, Durmus MS, Balkan II, Yildiz I, Ergul Y.
    Southeast Asian J Trop Med Public Health; 2012 Sep 10; 43(5):1178-85. PubMed ID: 23431824
    [Abstract] [Full Text] [Related]

  • 20. Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy.
    Corbellini S, Caccuri F, Gelmi M, De Francesco MA, Fiorentini S, Caruso A, Giagulli C.
    New Microbiol; 2014 Apr 10; 37(2):177-83. PubMed ID: 24858644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.